AHA urged CMS to “avoid unintended consequences” affecting the 340B program in public comments on the agency's plan to implement the Medicare Drug Price Negotiation Program.
AHA Urges CMS to Consider 340B When Implementing MDPNP, PhRMA Warns Against ‘Price Setting’